Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
1,928.00    36.00 (1.90%)
Bid:
1,912.00
Ask:
1,914.00
Spread: 2.00 (0.105%)
Market Cap: £3.24b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Johnson Matthey Battery Materials update

12 Jan 2022 14:19

RNS Number : 2549Y
Johnson Matthey PLC
12 January 2022
 

12th January 2022

 

Johnson Matthey Plc

(the Company)

Johnson Matthey provides an update on its intention to exit Battery Materials

 

Johnson Matthey, a global leader in sustainable technologies, today provides an update on its intention to exit Battery Materials.

 

On 11th November 2021, we announced our intention to pursue the sale of all or parts of our Battery Materials business with the ultimate intention of exiting. Further to that announcement, we have held discussions with a number of parties about a sale of the entire business. These discussions have not resulted in an agreement to sell the entire business as a going concern. Consequently, we are announcing today that we are commencing consultation with our employees about our proposed closure of the Battery Materials business, and we are pursuing the sale of its individual assets.

 

In our interim results we fully impaired the carrying value of our battery materials assets as at 30th September 2021, resulting in a charge of £314 million. While the outcome of the sales process is uncertain, full or partial closure will result in additional impairment charges, the settlement of contractual liabilities, redundancy, closure and abandonment costs as we indicated at our interim results on 24th November 2021. After anticipated asset disposal proceeds, we currently estimate these cash costs will be in the order of £150 million, which will be recorded as an exceptional item outside of underlying operating profit in our full year results.

 

 

ENDS

 

Enquiries: 

Investor Relations

Martin Dunwoodie

Louise Curran

Carla Fabiano

 

Director of Investor Relations

Senior Investor Relations Manager

Senior Investor Relations Manager

 

+44 20 7269 8241

+44 20 7269 8235

+44 20 7269 8004

 

Media

Barney Wyld

Harry Cameron

 

 

Group Corporate Affairs Director

Tulchan Communications

 

 

+44 7485 337498

+44 20 7353 4200

 

 

 

 

Johnson Matthey Plc is listed on the London Stock Exchange (JMAT)

Registered in England & Wales number: 00033774Legal Entity Identifier number: 2138001AVBSD1HSC6Z10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEALFAFFXAEFA
Date   Source Headline
21st Nov 20197:00 amRNSHalf-year Report
17th Oct 20193:46 pmRNSDirector/PDMR Shareholding
19th Sep 20194:21 pmRNSDirector/PDMR Shareholding
19th Sep 20197:00 amRNSJohnson Matthey Capital Markets Day
22nd Aug 20193:02 pmRNSDirector/PDMR Shareholding
22nd Aug 20192:55 pmRNSDirector/PDMR Shareholding
22nd Aug 20192:44 pmRNSDirector/PDMR Shareholding
22nd Aug 201911:53 amRNSDirector/PDMR Shareholding
12th Aug 20199:49 amRNSDirector/PDMR Shareholding
9th Aug 20199:45 amRNSDirector/PDMR Shareholding
9th Aug 20199:19 amRNSDirector/PDMR Shareholding
9th Aug 20199:06 amRNSDirector/PDMR Shareholding
8th Aug 20199:53 amRNSDirector/PDMR Shareholding
7th Aug 201912:42 pmRNSDirector/PDMR Shareholding
7th Aug 201912:33 pmRNSDirector/PDMR Shareholding
6th Aug 201911:06 amRNSDirector/PDMR Shareholding
6th Aug 201910:59 amRNSDirector/PDMR Shareholding
6th Aug 201910:54 amRNSDirector/PDMR Shareholding
2nd Aug 201911:40 amRNSDirector/PDMR Shareholding
2nd Aug 201911:33 amRNSDirector/PDMR Shareholding
19th Jul 20199:12 amRNSDirector/PDMR Shareholding
17th Jul 20193:24 pmRNSResult of AGM
17th Jul 20197:00 amRNSJohn Walker to retire; succeeded by Joan Braca
17th Jul 20197:00 amRNSAGM trading update
20th Jun 20192:05 pmRNSDirector/PDMR Shareholding
14th Jun 20197:00 amRNSAnnual Financial Report
30th May 20197:00 amRNSPreliminary results for year ended 31st March 2019
28th May 20197:00 amRNSDirectorate Changes
17th May 20192:03 pmRNSDirector/PDMR Shareholding
18th Apr 20193:41 pmRNSDirector/PDMR Shareholding
1st Apr 20197:00 amRNSDirectorate Change
28th Mar 20197:00 amRNSStrategic developments in eLNO commercialisation
21st Mar 20193:45 pmRNSDirector/PDMR Shareholding
21st Feb 20193:52 pmRNSDirector/PDMR Shareholding
7th Feb 20192:43 pmRNSDirector/PDMR Shareholding
7th Feb 20199:27 amRNSDirector/PDMR Shareholding
7th Feb 20199:25 amRNSDirector/PDMR Shareholding
7th Feb 20199:23 amRNSDirector/PDMR Shareholding
21st Jan 201910:43 amRNSDirector/PDMR Shareholding
17th Jan 20193:39 pmRNSDirector/PDMR Shareholding
21st Dec 20184:21 pmRNSDirector/PDMR Shareholding
11th Dec 201810:17 amRNSDirector/PDMR Shareholding
6th Dec 20185:22 pmRNSHolding(s) in Company
22nd Nov 201812:24 pmRNSDirector/PDMR Shareholding
21st Nov 20187:00 amRNSHalf-year Report
18th Oct 20184:20 pmRNSDirector/PDMR Shareholding
20th Sep 20184:42 pmRNSDirector/PDMR Shareholding
19th Sep 20183:57 pmRNSDirector/PDMR Shareholding
22nd Aug 201811:30 amRNSAlan Ferguson - New Directorship
16th Aug 20182:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.